Abstract
Background
Few studies have evaluated the recurrence of EGC after curative gastrectomy, due to its relatively low incidence. This study evaluated recurrence patterns and independent predictive factors for recurrence in order to determine appropriate follow-up and early detection of recurrence.
Methods
We reviewed the medical records of 3,883 consecutive patients who underwent curative gastrectomy for EGC at Samsung Medical Center between February 1995 and January 2006 and were followed up until January 2008. The clinical and pathological characteristics and the predictive factors for recurrence were evaluated retrospectively.
Results
Eighty-five (2.2%) patients had recurrence, and liver was the most common site of recurrence (45.9%). The recurrence rates within 2, 3, and 5 years were 43.5%, 67.1%, and 85.6%, respectively. There were 106 overall recurrences, with 86 (81.1%) being detected by computed tomography (CT). Second primary cancer was the primary cause of death after gastrectomy, followed by recurrence. Old age (>60 years), tumor size (>3 cm), multiple tumor, N category, and N2 station metastasis were significant factors for recurrence by multivariate analysis, but depth of invasion was not a significant factor.
Conclusions
Age, tumor size, number of tumors, N category, and N2 station metastasis were predictive factors for recurrence, with lymph node metastasis being the most significant factor. After curative gastrectomy, follow-up programs should be applied for more than 5 years for EGC patients, and computed tomography could be an essential diagnostic tool.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
2004 Nationwide Gastric Cancer Report in Korea. J Korean Gastric Cancer Assoc. 2007;7:47–54.
Basili G, Nesi G, Barchielli A, Manetti A, Biliotti G. Pathologic features and long-term results in early gastric cancer: report of 116 cases 8–13 years after surgery. World J Surg. 2003;27:149–52.
Borie F, Millat B, Fingerhut A, Hay JM, Fagniez PL, De Saxce B. Lymphatic involvement in early gastric cancer: prevalence and prognosis in France. Arch Surg. 2000;135:1218–23.
Gunji Y, Suzuki T, Hori S, Hayashi H, Matsubara H, Shimada H, et al. Prognostic significance of the number of metastatic lymph nodes in early gastric cancer. Dig Surg. 2003;20:148–53.
Kunisaki C, Shimada H, Takahashi M, Ookubo K, Moriwaki Y, Akiyama H, et al. Prognostic factors in early gastric cancer. Hepatogastroenterology. 2001;48:294–8.
Lee HJ, Kim YH, Kim WH, Lee KU, Choe KJ, Kim JP, et al. Clinicopathological analysis for recurrence of early gastric cancer. Jpn J Clin Oncol. 2003;33:209–14.
Sano T, Sasako M, Kinoshita T, Maruyama K. Recurrence of early gastric cancer. Follow-up of 1475 patients and review of the Japanese literature. Cancer. 1993;72:3174–8.
Shimada S, Yagi Y, Shiomori K, et al. Characterization of early gastric cancer and proposal of the optimal therapeutic strategy. Surgery. 2001;129:714–9.
Kunisaki C, Akiyama H, Nomura M, et al. Significance of long-term follow-up of early gastric cancer. Ann Surg Oncol. 2006;13:363–9.
Sobin LH, Wittekind CH, editors. UICC (International union against cancer), TNM classification of malignant tumors. 6th ed. 2002.
Japanese Gastric Cancer A. Japanese classification of gastric carcinoma—2nd English edition. Gastric Cancer. 1998;1:10–24.
Kikuchi S, Katada N, Sakuramoto S, Kobayashi N, Shimao H, Watanabe M, et al. Survival after surgical treatment of early gastric cancer: surgical techniques and long-term survival. Langenbecks Arch Surg. 2004;389:69–74.
Kim DY, Joo JK, Ryu SY, Kim YJ, Kim SK. Factors related to lymph node metastasis and surgical strategy used to treat early gastric carcinoma. World J Gastroenterol. 2004;10:737–40.
Kunisaki C, Shimada H, Nomura M, Akiyama H. Appropriate lymph node dissection for early gastric cancer based on lymph node metastases. Surgery. 2001;129:153–7.
Saito H, Osaki T, Murakami D, et al. Recurrence in early gastric cancer–presence of micrometastasis in lymph node of node negative early gastric cancer patient with recurrence. Hepatogastroenterology. 2007;54:620–4.
Yuasa N, Nimura Y. Survival after surgical treatment of early gastric cancer, surgical techniques, and long-term survival. Langenbecks Arch Surg. 2005;390:286–93.
D’Angelica M, Gonen M, Brennan MF, Turnbull AD, Bains M, Karpeh MS. Patterns of initial recurrence in completely resected gastric adenocarcinoma. Ann Surg. 2004;240:808–16.
Yoo CH, Noh SH, Shin DW, Choi SH, Min JS. Recurrence following curative resection for gastric carcinoma. Br J Surg. 2000;87:236–42.
Otsuji E, Kuriu Y, Ichikawa D, Okamoto K, Hagiwara A, Yamagishi H. Tumor recurrence and its timing following curative resection of early gastric carcinoma. Anticancer Res. 2003;23:3499–503.
Yamamoto M, Yamanaka T, Baba H, Kakeji Y, Maehara Y. The postoperative recurrence and the occurrence of second primary carcinomas in patients with early gastric carcinoma. J Surg Oncol. 2008;97:231–5.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Youn, H.G., An, J.Y., Choi, M.G. et al. Recurrence After Curative Resection of Early Gastric Cancer. Ann Surg Oncol 17, 448–454 (2010). https://doi.org/10.1245/s10434-009-0772-2
Received:
Published:
Issue Date:
DOI: https://doi.org/10.1245/s10434-009-0772-2